(Boston)—Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a major global health threat that acts as the primary vector for several severe diseases, most notably dengue fever, as well as yellow fever, chikungunya and Zika virus. Local government agencies conduct routine molecular surveillance of these mosquitoes to detect and track viruses, however, they are primarily limited to using conventional reverse transcription polymerase chain reaction methodologies, which can only detect known pathogens that have already been identified and for which specific genetic primers have been developed.
Recent research efforts applying high-throughput RNA sequencing have led to a large expansion in the mosquito virome (the entire collection of viruses contained within mosquitoes). However, questions remain as to how persistent insect viruses are within mosquito colonies, how insect viruses interact with mosquito immune responses and how frequently insect viruses can be transmitted.
A new study by Boston University Chobanian & Avedisian School of Medicine researchers looked at the mosquitoes’ immune response to discover many more insect viruses and they hope to someday use the mosquitoes’ own immune system to battle some of the most pervasive and antagonistic human viruses.
Viruses that replicate in mosquitoes generate double-stranded RNA molecules, and its RNAi pathway allows them to tolerate the replicating virus by inactivating the virus RNA genome into virus small RNA fragments (vsmRNAs). The researchers hypothesized that by tracking vsmRNAs that are triggering the mosquito’s innate immune response of RNA interference (RNAi), we could help municipal insect control groups learn just how many viruse are residing in the Aedes aegypti mosquitoes that swarm cities with warm climates like Miami and Sacramento.
“In our study, we discovered that these mosquitoes are heavily infected with many, viruses, some that are globally distributed while others are unique to one continent like the Formosus virus that is just in mosquito strains originating from Africa. These viruses are constantly battling the mosquito's immune system, and by studying the viral small RNAs, we can discover new viruses and understand how mosquitoes enable viral disease transmission,” explains corresponding author Nelson Lau, PhD, associate professor of biochemistry and director of the BU Genome Science Institute at the school.
The researchers collected Aedes aegypti mosquitoes from North America, Central America, Africa and Asia to sample and sequence the small RNAs from these samples. By comparing long viral RNAs (the active virus) with viral small RNAs (the immune response), the researchers discovered that some viruses can evade or "hide" from the mosquito's RNAi pathway—the main defense mechanism mosquitoes use to fight infection. They then developed bioinformatics analysis pipelines to match the small RNAs to databases of potentially new viruses that ecologists and epidemiologists are currently discovering from mosquito field studies all around the world.
“By discovering new mosquito viruses that can generate robust RNAi responses in mosquito cell cultures, we now want to develop these entities as tools to treat non-infected mosquitoes, perhaps inoculate mosquitoes to be more resistant against the pathogenic arboviruses that cause human diseases,” said Lau.
These findings appear online in journal Nature Communications.
N.C.L.’s lab was funded by an NIH/NIGMS grant #R01GM135215 and a subcontract from grant #R15AI171800-01A1. L.L. was supported by the French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID). A.B. was supported by a stipend from the Pasteur - Paris University (PPU) International PhD Program. A.E.W. and K.E.O. were supported by NIH grant #R01AI130085. A.E.W. and E.C. research was supported by the Intramural Research Program of NIH/NIAID (AI001246). N.H.R and C.S.M.’s work here was supported by NIH grant #R00DC012069 and a New York Stem Cell Foundation Robertson Neuroscience Investigator Award. A.L.C.S. and M.D. were supported by U.S. Centers for Disease Control and Prevention (CDC) Cooperative Agreement Number 1U01CK000510, Southeastern Regional Center of Excellence in Vector-Borne Diseases Gateway Program. D.E.B.’s work was supported in part by grants from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (AI148477). M.A.Y. is supported by the Searle Scholars Program, the Richard and Susan Smith Family Foundation, the Esther A. & Joseph Klingenstein Fund, and the Simons Foundation.
Nature Communications
Observational study
Animals
Small RNA genomics of Aedes aegypti mosquitoes discovers infectious viruses that trigger an RNA interference response
23-Apr-2026